Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience

PURPOSE: Both gefitinib and pemetrexed maintenance were effective therapies for advanced lung adenocarcinoma, but which is better is unclear. For patients with advanced lung adenocarcinoma, we have no idea whether we should choose gefitinib or pemetrexed maintenance in clinical practice. Here, we as...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Liping, Zhao, Juanjuan, Hu, Jiazhu, Huang, Fuxi, Han, Jianjun, He, Yan, Cao, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072510/
https://www.ncbi.nlm.nih.gov/pubmed/27789961
http://dx.doi.org/10.2147/OTT.S113374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072510/
https://www.ncbi.nlm.nih.gov/pubmed/27789961
http://dx.doi.org/10.2147/OTT.S113374

Ejemplares similares